Derleme
BibTex RIS Kaynak Göster

Premenstrüel Sendrom: Farmakolojik Olmayan Yönetim ve Öneriler

Yıl 2025, Cilt: 5 Sayı: 1, 72 - 90, 31.01.2025
https://doi.org/10.52369/togusagbilderg.1465122

Öz

Premenstrüel Sendrom (PMS), premenstrüel dönemde ortaya çıkan fiziksel, davranışsal ve psikolojik semptomlarla karakterizedir. Semptomlar arasında irritabilite, ruh hali değişiklikleri, kaygı, depresyon, yorgunluk, uyku bozuklukları, konsantrasyon zorluğu, şişkinlik ve baş ağrıları bulunur. PMS semptomları kadınların günlük aktivitelerini olumsuz etkileyebilir ve sosyal ilişkilerini bozabilir. Öğrencilerde ise akademik performansın düşmesine neden olabilir. Türkiye'de, PMS yaygınlığı %52,2'dir ve küresel olarak, yaklaşık her iki kadından biri PMS'den etkilenmektedir. PMS'nin tam olarak nedenleri tam olarak anlaşılmamış olsa da, hormonal ve nörotransmitter etkileşimlerinin rol oynadığı düşünülmektedir. Eğitim düzeyi, sosyoekonomik durum, beslenme alışkanlıkları, stres düzeyleri ve ailede PMS öyküsü gibi faktörler gelişimine katkıda bulunabilir. PMS tanısı için belirli bir kan testi olmamasına rağmen, semptomların izlenmesi ve belirli kriterlerle uyumlarının değerlendirilmesi ile tanı konulabilir. PMS'nin ilaç dışı yönetimi; yaşam tarzı değişikliklerini, geleneksel ve tamamlayıcı tıp uygulamalarını, psikoterapi, destek sistemlerini ve hasta eğitimlerini içerir. Bu derleme, PMS'nin ilaç dışı yönetimi ve önerileri inceleyerek sağlık profesyonellerinde bu konudaki farkındalık bilincini artırmayı ve etkili müdahale stratejilerinin geliştirilmeyi hedeflemektedir.

Etik Beyan

Etik izne tabi değildir

Destekleyen Kurum

Yoktur

Proje Numarası

yok

Teşekkür

Yoktur

Kaynakça

  • 1. Pearce E, Jolly K, Jones LL, Matthewman G, Zanganeh M, Daley A. Exercise for premenstrual syndrome: A systematic review and meta-analysis of randomised controlled trials. BJGP Open. 2020;4(3).
  • 2. Yilmaz Akyuz E, Aydin Kartal Y. The effect of diet and aerobic exercise on premenstrual syndrome: Randomized controlled trial. Revista de Nutricao. 2019;32:e180246.
  • 3. Womens Health Concern. Premenstrual Syndrome (PMS)[İnternet]. 2012 [Accessed on 12 March 2023].Access address:https://www.womens-health-concern.org/wp-content/uploads/2015/02/WHC_FS_PMS.pdf
  • 4. Atim E, Okecho FN, Ndagire R, Lwanira Nassozi CL. Prevalence and severity of premenstrual syndrome among female university students in central Uganda: a cross-sectional study. SJHR-Africa. 2022;3(9):10.
  • 5. Çitil ET, Kaya N. Effect of pilates exercises on premenstrual syndrome symptoms: a quasi-experimental study. Complement Ther Med. 2021;57:102623.
  • 6. Kamalifard M, Yavari A, Asghari Jafarabadi M, Ghaffarilaleh G, Kasb Khah, A. The effect of yoga on women’s premenstrual syndrome: A randomized controlled clinical trial. International Journal of Women’s Health and Reproduction Sciences (IJWHR). 2017;5(3):205–211.
  • 7. Carlini SV, Lanza di Scalea T, McNally ST, Lester J, Deligiannidis KM. Management of premenstrual dysphoric disorder: a scoping review. International Journal of Women's Health. 2022; 21(14):1783-1801.
  • 8. Ducasse D, Jaussent I, Olié E, Guillaume S, Lopez-Castroman J, Courtet P. Personality traits of suicidality are associated with premenstrual syndrome and premenstrual dysphoric disorder in a suicidal women sample. PLoS ONE. 2016;11(2):1-19.
  • 9. Minichil W, Eskindir E, Demilew D, Mirkena Y. Magnitude of premenstrual dysphoric disorder and its correlation with academic performance among female medical and health science students at University of Gondar, Ethiopia, 2019: a cross-sectional study. BMJ Open. 2020;10:34166.
  • 10. Erbil N, Yücesoy H. Premenstrual syndrome prevalence in Turkey: a systematic review and meta-analysis. Psychol Health Med. 2023;28(5):1347-57.

Premenstrual Syndrome: Non-pharmacological Management and Recommendations

Yıl 2025, Cilt: 5 Sayı: 1, 72 - 90, 31.01.2025
https://doi.org/10.52369/togusagbilderg.1465122

Öz

Premenstrual Syndrome (PMS) is characterized by physical, behavioral, and psychological symptoms that manifest during the premenstrual phase. Symptoms include irritability, mood swings, anxiety, depression, fatigue, sleep disturbances, difficulty concentrating, bloating, and headaches. PMS symptoms can adversely affect women's daily activities and disrupt their social relationships. In students, it can lead to a decline in academic performance. In Turkey, the prevalence of PMS is 52.2%, and globally, approximately one in every two women is affected by PMS. While the exact etiology of PMS remains unclear, hormonal and neurotransmitter interactions are believed to play a role. Factors such as educational level, socioeconomic status, dietary habits, stress levels, and family history of PMS may contribute to its development. Although there is no specific blood test for diagnosing PMS, diagnosis can be made by monitoring symptoms and assessing their adherence to specific criteria. Non-pharmacological management of PMS includes lifestyle modifications, traditional and complementary medicine practices, psychotherapy, support systems, and patient education. This review aims to enhance awareness among healthcare professionals regarding non-pharmacological management and recommendations for PMS, aiming to develop effective intervention strategies.

Proje Numarası

yok

Kaynakça

  • 1. Pearce E, Jolly K, Jones LL, Matthewman G, Zanganeh M, Daley A. Exercise for premenstrual syndrome: A systematic review and meta-analysis of randomised controlled trials. BJGP Open. 2020;4(3).
  • 2. Yilmaz Akyuz E, Aydin Kartal Y. The effect of diet and aerobic exercise on premenstrual syndrome: Randomized controlled trial. Revista de Nutricao. 2019;32:e180246.
  • 3. Womens Health Concern. Premenstrual Syndrome (PMS)[İnternet]. 2012 [Accessed on 12 March 2023].Access address:https://www.womens-health-concern.org/wp-content/uploads/2015/02/WHC_FS_PMS.pdf
  • 4. Atim E, Okecho FN, Ndagire R, Lwanira Nassozi CL. Prevalence and severity of premenstrual syndrome among female university students in central Uganda: a cross-sectional study. SJHR-Africa. 2022;3(9):10.
  • 5. Çitil ET, Kaya N. Effect of pilates exercises on premenstrual syndrome symptoms: a quasi-experimental study. Complement Ther Med. 2021;57:102623.
  • 6. Kamalifard M, Yavari A, Asghari Jafarabadi M, Ghaffarilaleh G, Kasb Khah, A. The effect of yoga on women’s premenstrual syndrome: A randomized controlled clinical trial. International Journal of Women’s Health and Reproduction Sciences (IJWHR). 2017;5(3):205–211.
  • 7. Carlini SV, Lanza di Scalea T, McNally ST, Lester J, Deligiannidis KM. Management of premenstrual dysphoric disorder: a scoping review. International Journal of Women's Health. 2022; 21(14):1783-1801.
  • 8. Ducasse D, Jaussent I, Olié E, Guillaume S, Lopez-Castroman J, Courtet P. Personality traits of suicidality are associated with premenstrual syndrome and premenstrual dysphoric disorder in a suicidal women sample. PLoS ONE. 2016;11(2):1-19.
  • 9. Minichil W, Eskindir E, Demilew D, Mirkena Y. Magnitude of premenstrual dysphoric disorder and its correlation with academic performance among female medical and health science students at University of Gondar, Ethiopia, 2019: a cross-sectional study. BMJ Open. 2020;10:34166.
  • 10. Erbil N, Yücesoy H. Premenstrual syndrome prevalence in Turkey: a systematic review and meta-analysis. Psychol Health Med. 2023;28(5):1347-57.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Ebelik (Diğer)
Bölüm Derlemeler
Yazarlar

Merve Sezer Yıldız 0000-0001-7061-3302

Özlem Çağan 0000-0001-8671-3279

Proje Numarası yok
Yayımlanma Tarihi 31 Ocak 2025
Gönderilme Tarihi 4 Nisan 2024
Kabul Tarihi 25 Ocak 2025
Yayımlandığı Sayı Yıl 2025 Cilt: 5 Sayı: 1

Kaynak Göster

Vancouver Sezer Yıldız M, Çağan Ö. Premenstrual Syndrome: Non-pharmacological Management and Recommendations. TOGÜ Sağlık Bilimleri Dergisi. 2025;5(1):72-90.